Tuesday, February 19, 2008
Subscribe to:
Post Comments (Atom)
skip to main |
skip to sidebar
Email
Psychiatric medications, science, marketing, psychiatry in general, and occasionally clinical psychology. Questioning the role of key opinion leaders and the use of "science" to promote commercial ends rather than the needs of people with mental health concerns.
Blog Archive
-
▼
2008
(103)
-
▼
February
(13)
- Misconduct: Where are the Consequences?
- Nominee for Career Achievement Award: Dr. David Li...
- Scientific Misconduct, Version 4309
- Antidepressants: Meet the New News, Same as the Ol...
- Welfare Queens on Fiapta Demand Confidential Peer ...
- American Psychological Association: A Wink and Nod...
- Medical Bribery: We Want Details
- Andorra Ain't In Africa?
- Why I Love the Discussion Section
- Key Opinion Leaders and Information Laundering: Th...
- Today's Teachers Tackle The Tough Issues
- Go To Furious Seasons
- Mood Stablizers and Suicide
-
▼
February
(13)
Academia
Pharma: General
Psychiatry and Psychology
Scientific Misconduct
About Me
- CL Psych
- I'm an academic with a respectable amount of clinical experience and no drug industry funding. Given my lack of time, don't expect multiple daily updates. Certain things about clinical psychology, the drug industry, psychiatry, and academics drive me nuts, and you'll probably pick up on these pet peeves before long...
Translate this page
Subscribe Via Email
1 comment:
Just more proof that the Onion News Network (ONN) provides the best News coverage out there, bringing you the stories that the Mainstream Liberal Media refuse to air.
Great work, ONN!
Post a Comment